{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-235413","form_type":"8-K","ticker":"BHC","cik":"0000885590","company_name":"Bausch Health Companies Inc.","filed_at":"2023-09-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:36.877602+00:00","generated_at":"2026-06-10T18:21:53.864145+00:00","sec_items":["8.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Bausch + Lomb subsidiary prices $1.4B 8.375% senior secured notes due 2028","bullets":["Bausch + Lomb subsidiary Bausch + Lomb Escrow Corp. priced $1.4B of 8.375% senior secured notes due 2028.","Notes priced at 100% of principal; exempt from registration under Securities Act and Canadian securities laws.","Proceeds expected to fund pending acquisition of XIIDRA and other ophthalmology assets.","Offering is part of Bausch + Lomb's financing for the acquisition."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-235413","json":"https://secwatch.observer/filing/0001193125-23-235413.json","markdown":"https://secwatch.observer/filing/0001193125-23-235413.md","text":"https://secwatch.observer/filing/0001193125-23-235413.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/885590/000119312523235413/0001193125-23-235413-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/885590/000119312523235413/d507768d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T18:21:53.864145+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}